“…Across a total of 21 published studies meeting our inclusion criteria, we identified 706 patients with 721 dAVFs treated with SRS. 12,13,[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45] Patients were treated between 1994 and 2021 at institutions in the United States, Sweden, Canada, the United Kingdom, South Korea, Taiwan, Japan, Spain, and India. Data on both outcomes as well as patient age, median clinical and angiographic follow-up, proportion of patients who received previous surgery and/or embolization, the proportion of patients with previous hemorrhage or CVD, target volume size and Borden Class, and MPD are detailed in Table 1.…”